Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Psychopharmacology

Psychopharmacology

In the last century discoveries in psychopharmacology transformed psychiatry and radically improved the treatment of serious mental illness. Drug treatment still plays an important role in the treatment of serious psychiatric disorder but it is important to improve current pharmacological treatments in terms of both effectiveness and safety. In the Department we investigate all aspects of psychopharmacology from molecular studies to experimental medicine through to large-scale clinical trials.

Groups within this theme

Psychotropic drug treatment is often prescribed to help people with mental health problems but its use can be controversial. The work of the group aims to understand how psychotropic drugs work from a molecular level through to clinical research in patients.

Clinical Psychopharmacology

Using computer models of behaviour, we aim to better understand anxiety and depression, and to guide the development of novel treatments.

Computational Psychiatry

Our research includes projects in the epidemiology of mental illness and violent crime, violence risk assessment, prison health, pharmacoepidemiology studies, forensic services, and suicide and self-harm in prisoners and offenders.

Forensic Psychiatry

Our research aims to understand how individual genes contribute to the complex brain functions that are impaired in people with psychiatric disorders. By understanding these links we hope to improve treatments for these disorders.

Neural Correlates of Gene Function

We are dedicated to testing and developing new ways of improving treatments for psychiatric disorders, and maintaining brain health during aging. A significant proportion of people suffering from disturbances of mood and memory, do not respond to the available medication, and so there is an urgency to supplement or provide an alternative to current therapies.

Neurobiology and Experimental Therapeutics

Why do some people suffer from depression and memory loss as they age, whereas others stay well for the whole of their lives? We examine the effect of genes and life history on ageing using neuropsychology and neuro-imaging techniques as part of large scale epidemiological and experimental medicine studies.

Neurobiology of Ageing

We design and conduct clinical trials in cognitive health and neuroscience. Our trials include evaluations of promising new therapies, direct comparisons of current treatments and health services research.

Oxford Cognitive Health and Neuroscience Clinical Trials Unit

We explore how the brain processes emotional information and how this is influenced by brain chemicals and medicines. This helps us to understand disorders such as depression and anxiety and to understand and contribute to the development of drug and psychological treatments.

Psychopharmacology and Emotion Research Laboratory

We are interested in the molecular and neural basis of schizophrenia and bipolar disorder, and how the risk genes for these disorders operate. We use a range of platforms, methods, and collaborations, to carry out this work.

Translational Neurobiology of Psychosis

We have three main areas of activity, all aiming towards secondary prevention of dementia. By understanding disease mechanisms we seek potential therapeutics; through discovery of biomarkers we hope to enable preventative trials, and with informatics we utilise large biological and clinical datasets in the support of translational neuroscience.

Translational Neuroscience & Dementia Research

Publications

Find all our latest publications here

RESEARCH THEMES & GROUPS